We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$925M
AUM Growth
+$432M
Cap. Flow
+$266M
Cap. Flow %
28.73%
Top 10 Hldgs %
21.37%
Holding
202
New
35
Increased
66
Reduced
37
Closed
34

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$16.3M
2
SDGR icon
Schrodinger
SDGR
+$16.2M
3
ARGX icon
argenx
ARGX
+$16.2M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$14.7M
5
RGEN icon
Repligen
RGEN
+$14.2M

Top Sells

Rank Stock Value
1
DKS icon
Dick's Sporting Goods
DKS
+$6.73M
2
CALY
Callaway Golf Company
CALY
+$6.16M
3
FTDR icon
Frontdoor
FTDR
+$5.3M
4
SMAR
Smartsheet Inc.
SMAR
+$4.04M
5
PZZA icon
Papa John's
PZZA
+$3.52M

Sector Composition

Rank Sector Weight
1 Healthcare 48.41%
2 Technology 11.82%
3 Consumer Discretionary 8.18%
4 Industrials 6.85%
5 Communication Services 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCPH
26
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$11.1M 1.2%
216,983
+169,872
+361% +$8.32M
BBIO icon
27
BridgeBio Pharma
BBIO
$16.5B
$11M 1.19%
292,982
+239,626
+449% +$7.54M
PODD icon
28
Insulet
PODD
$9.79B
$10.6M 1.14%
44,738
+36,675
+455% +$7.72M
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.77B
$10.4M 1.13%
74,412
+61,844
+492% +$9.4M
GBT
30
DELISTED
Global Blood Therapeutics, Inc.
GBT
$10.4M 1.13%
189,392
+152,293
+411% +$9.68M
PEN icon
31
Penumbra
PEN
$12.8B
$10.1M 1.09%
51,780
+44,212
+584% +$9.3M
TFII icon
32
TFI International
TFII
$11.5B
$9.76M 1.06%
233,382
+54,185
+30% +$2.28M
KRYS icon
33
Krystal Biotech
KRYS
$9.66B
$9.57M 1.04%
222,422
+182,914
+463% +$7.94M
AFIB
34
DELISTED
Acutus Medical Inc
AFIB
$9.55M 1.03%
+320,627
New +$9.73M
ESPR
35
DELISTED
Esperion Therapeutics
ESPR
$8.77M 0.95%
235,855
+202,240
+602% +$8.01M
ESTC icon
36
Elastic
ESTC
$7.81B
$8.75M 0.95%
81,136
+1,995
+3% +$196K
IIPR icon
37
Innovative Industrial Properties
IIPR
$1.72B
$8.71M 0.94%
70,221
+27,341
+64% +$3.06M
CALY
38
Callaway Golf Company
CALY
$3.14B
$8.33M 0.9%
435,336
-327,998
-43% -$6.16M
TRIL
39
DELISTED
Trillium Therapeutics Inc.
TRIL
$8.15M 0.88%
+573,629
New +$5.72M
AMRC icon
40
Ameresco
AMRC
$1.36B
$7.5M 0.81%
+224,545
New +$6.8M
CHGG icon
41
Chegg
CHGG
$102M
$7.37M 0.8%
103,214
+3,369
+3% +$248K
BMRN icon
42
BioMarin Pharmaceuticals
BMRN
$12.4B
$7.33M 0.79%
+96,276
New +$9.74M
TREX icon
43
Trex
TREX
$5.01B
$7.3M 0.79%
101,952
+2,406
+2% +$166K
HOUS
44
DELISTED
Anywhere Real Estate
HOUS
$6.68M 0.72%
+707,244
New +$6.79M
SAGE
45
DELISTED
Sage Therapeutics
SAGE
$6.46M 0.7%
+105,771
New +$5.36M
TGTX icon
46
TG Therapeutics
TGTX
$7.62B
$6.14M 0.66%
+229,452
New +$5.28M
MDLA
47
DELISTED
Medallia, Inc.
MDLA
$6.11M 0.66%
222,637
+21,384
+11% +$649K
CACI icon
48
CACI
CACI
$14.2B
$6.02M 0.65%
28,250
-5,678
-17% -$1.23M
BAC.PRL icon
49
Bank of America Series L
BAC.PRL
$3.99B
– –
0
– –
PLMR icon
50
Palomar
PLMR
$3.45B
$5.88M 0.64%
56,451
-6,694
-11% -$656K
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Nicholas Investment Partners held 202 positions worth $925M, up 88% from $493M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners deployed $266M of net new capital in Q3 2020, opening 35 new positions and adding to 66 existing holdings. Its largest new stake was Schrodinger: 235,823 shares worth $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Callaway Golf Company, an estimated $6.16M trimmed.

  • Nicholas Investment Partners's largest Q3 2020 buy was Schrodinger: 235,823 shares worth $11.2M.
  • Nicholas Investment Partners added most to Teladoc Health in Q3 2020, an estimated $16.3M increase.
  • Nicholas Investment Partners's biggest Q3 2020 reduction was Callaway Golf Company, cutting an estimated $6.16M.
  • Nicholas Investment Partners fully exited Dick's Sporting Goods in Q3 2020, selling an estimated $6.73M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $925M portfolio in Q3 2020.
  • Nicholas Investment Partners opened 35 new positions and closed 34 in Q3 2020.
  • Nicholas Investment Partners's portfolio value rose 88% quarter-over-quarter to $925M.

Based on Nicholas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.